Validation of unification of splenic hardness measurement to elucidate the pathogenesis of portal hypertension

Validation of unification of splenic hardness measurement to elucidate the pathogenesis of portal hypertension - Validation of unification of splenic hardness measurement to elucidate the pathogenesis of portal hypertension

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052852

Enrollment

200

Registered

2023-11-21

Start date

2023-10-12

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following conditions are eligible 1) Patients with diffuse liver disease (2) Patients who are 15 years of age or older at the time of consent (3) Patients who have been fully informed of the study and who have given their voluntary written consent based on their full understanding of the study. 4) For minors under 18 years of age, patients who have obtained written consent from a surrogate.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following conditions will not be included in the study 1) Patients who are tested in the usual course of medical care and who are deemed by the investigator or subinvestigator to be unsuitable for the safe conduct of this study.

Design outcomes

Primary

Measure	Time frame
Correlation between splenic hardness and hepatic venous pressure gradient (HVPG)	—

Countries

Japan

Contacts

Public ContactHidemi Unozawa

Chiba University Hospital Gastroenterology

unozawa.hidemi@chiba-u.jp43222717

Outcome results